These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1577392

  • 1. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC.
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole: a new approach to gastric acid suppression.
    Buhl K, Clearfield HR.
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [Abstract] [Full Text] [Related]

  • 3. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE.
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [Abstract] [Full Text] [Related]

  • 4. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 5. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Jun; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 7. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993 Apr; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

  • 8. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S, Santucci L, Morelli A.
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [Abstract] [Full Text] [Related]

  • 9. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ.
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [Abstract] [Full Text] [Related]

  • 10. Omeprazole: a comprehensive review.
    Massoomi F, Savage J, Destache CJ.
    Pharmacotherapy; 1993 Sep; 13(1):46-59. PubMed ID: 8437967
    [Abstract] [Full Text] [Related]

  • 11. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR.
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [Abstract] [Full Text] [Related]

  • 13. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 14. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Aug; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG.
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 17. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 18. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE, Sabesin SM, Kogut DG, Kerr RM, Wruble LD, Collen MJ.
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [Abstract] [Full Text] [Related]

  • 19. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
    Koop H, Katschinski M, Arnold R.
    Med Klin (Munich); 1991 Nov 15; 86(11):566-8. PubMed ID: 1685214
    [Abstract] [Full Text] [Related]

  • 20. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Nov 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.